Pinedo Prize Awardees   The following distinguished physician-scientists have earned the prestigious Pinedo Cancer Care Prize.   2011 Award: Gabriel N. Hortobágyi, The University  of Texas MD Anderson Cancer Center   Professor Hortobágyi is widely recognized for developing combined modality therapy for previously inoperable breast tumors, improving multidisciplinary treatment for patients with all stages of the disease and conducting clinical trials to develop treatment regimens that have become standard practices for managing breast cancer. A past president of ASCO, he is on the Board of Directors of the Conquer Cancer Foundation and has previously held leadership positions with Susan G. Komen for the Cure and the International Association of Breast Cancer Research. He has been recognized for his groundbreaking research efforts with many awards, including honorary doctorates from 3 leading universities in Italy, Mexico and Argentina.    Professor Hortobágyi was awarded the 2011Pinedo Cancer Care Prize at the STO meeting in Belfast, Northern Ireland on September 7, 2011. He presented the keynote lecture “Towards Individualized Breast Cancer Therapy: Translating Biological Concepts to the Bedside” which can be viewed online here.    2010 Award: José Baselga, Massachusetts General Hospital Cancer Center   Professor Baselga relocated from Barcelona, Spain in the summer of 2010 to become chief of the Division of Hematology/Oncology and associate director of the Mass General Cancer Center. He has made seminal advances in breast cancer research, developing new, targeted cancer-fighting agents.  Prof. Baselga was chairman of the Medical Oncology Service and founder and director of the Division of Medical Oncology, Hematology and Radiation Oncology at the Vall d’Hebron Institute of Oncology, Barcelona, Spain. He was a professor of medicine at the Universidad Autonoma de Barcelona. A recipient of many distinguished awards, Prof. Baselga also received from Queen Sofia of Spain the coveted Echevarne Foundation National Prize in Oncology, one of Spain’s highest honors.   2009 Award: Richard J. O’Reilly, Memorial Sloan-Kettering Cancer Center   Professor O’Reilly is known for pioneering bone marrow transplantation research spanning more than three decades.  He started the clinical and preclinical research program in Memorial Sloan-Kettering Cancer Center in New York and established a worldwide reputation for bone marrow transplantations of children with severe combined immune deficiencies and leukemias.  He is Chair of Sloan-Kettering’s department of pediatrics and Chief of the pediatric bone marrow transplant service.   2008 Award: Bob Löwenberg, Erasmus Medical Center, Rotterdam   Professor Löwenberg is Professor of Hematology and since 1990 has been Department Chair at Erasmus University Medical Center in Rotterdam, the Netherlands.  Prof. Löwenberg’s research activities are in the treatment and the pathobiology of leukemia, lymphoma and stem cell transplantation.  He is extensively published in the area of development diagnostics and therapeutics in leading scientific journals.  Prof. Löwenberg is on the editorial board of several international journals.  He was one of the founders and has served as President of the European Haematology Association (EHA). He has also served as president of the International Society of Experimental Hematology and the International Society of Hematology. In 2011, he was appointed editor of Blood.    2007 Award: Joseph R. Bertino, New Jersey Cancer Center   Professor Bertino has been internationally recognized for his role in finding curative treatments for leukemia and lymphoma. He is University Professor of medicine and pharmacology, UMDNJ-Robert Wood Johnson Medical School and is the interim director of the school’s Cancer Institute of New Jersey in New Brunswick. He was named interim director of the Stem Cell Institute of New Jersey in 2007. He has been an American Cancer Society professor since 1976. Prof. Bertino joined The Cancer Institute of New Jersey in 2002 as associate director and was appointed chief scientific officer in 2004. 2006 Inaugural Award: Bruce A. Chabner, Massachusetts General Hospital Cancer Center   Professor Chabner, an internationally renowned oncologist and cancer pharmacologist, has devoted both his clinical and research careers to the improvement of patient treatment and care affecting patients throughout the world. One of the unique and very important features of Dr. Chabner’s career has been his continued focus on the improvement of treatments for patients, and to this day this remains his major goal.  His work has led to significant advances in the quality of care provided to patients.  During his tenure at the NCI and Harvard Medical School, he has been involved in leading therapeutic advance such as high-dose therapies as well as targeted therapies for lymphoma, colorectal cancer and breast cancer.